Timetric's "HAEMATO AG - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, key competitors, financial analysis, key employees as well as company locations and subsidiaries.
This report is a crucial resource for industry executives and anyone looking to access key information about "HAEMATO AG"
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Identifies crucial company information about "HAEMATO AG" along with major products and services for business intelligence requirements.
Provides key ratios on company's financial performance.
Identifies key employees to assist with key business decisions.
Provides annual and interim financial ratios.
Reasons To Buy
Enhance your understanding of "HAEMATO AG"
Increase business/sales activities by understanding customers’ businesses better.
Recognize potential partnerships and suppliers.
Qualify prospective partners, affiliates or suppliers.
Acquire up-to-date company information and an understanding of the company’s financial health.
Haemato is engaged in the healthcare business. It focuses on the marketing of patent free generics and patent protected active ingredients that cover therapeutic areas in oncology, human immunodeficiency virus (HIV/Aids), rheumatology, neurology, cardiovascular diseases. Haemato, through its subsidiary, HAEMATO PHARM, is engaged in the marketing and trading of generics such as oncological pharmaceuticals, and sale of branded pharmaceuticals; procurement, licensing and marketing of branded and generic pharmaceuticals. The company operates in Germany, the Netherlands and Thailand. It is headquartered in Schonefeld, Germany.